Commonwealth Equity Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 2025 Q3 | $5.77M | Buy |  | |||||
| 2025 Q2 | $2.73M | Sell |  | |||||
| 2025 Q1 | $2.55M | Buy |  | |||||
| 2024 Q4 | $3.49M | Sell |  | |||||
| 2024 Q3 | $3.13M | Buy |  | |||||
| 2024 Q2 | $2.65M | Sell |  | |||||
| 2024 Q1 | $3.81M | Sell |  | |||||
| 2023 Q4 | $3.22M | Buy |  | |||||
| 2023 Q3 | $2.61M | Buy |  | |||||
| 2023 Q2 | $1.83M | Buy |  | |||||
| 2023 Q1 | $1.51K | Buy |  | |||||
| 2022 Q4 | $1.1M | Buy |  | |||||
| 2022 Q3 | $968K | Sell |  | |||||
| 2022 Q2 | $961K | Sell |  | |||||
| 2022 Q1 | $1.22M | Sell |  | |||||
| 2021 Q4 | $1.16M | Sell |  | |||||
| 2021 Q3 | $1.63M | Sell |  | |||||
| 2021 Q2 | $1.68M | Sell |  | |||||
| 2021 Q1 | $2.11M | Buy |  | |||||
| 2020 Q4 | $1.63M | Buy |  | |||||
| 2020 Q3 | $1.43M | Sell |  | |||||
| 2020 Q2 | $2.28M | Sell |  | |||||
| 2020 Q1 | $1.69M | Buy |  | |||||
| 2019 Q4 | $1.59M | Sell |  | |||||
| 2019 Q3 | $1.17M | Buy |  | |||||
| 2019 Q2 | $1.48M | Buy |  | |||||
| 2019 Q1 | $2.43M | Sell |  | |||||
| 2018 Q4 | $2.48M | Sell |  | |||||
| 2018 Q3 | $3.97M | Buy |  | |||||
| 2018 Q2 | $3.87M | Sell |  | |||||
| 2018 Q1 | $2.83M | Buy |  | |||||
| 2017 Q4 | $3.11M | Buy |  | |||||
| 2017 Q3 | $2.82M | Sell |  | |||||
| 2017 Q2 | $5.58M | Buy |  | |||||
| 2017 Q1 | $5.3M | Buy |  | |||||
| 2016 Q4 | $4.94M | Buy |  | |||||
| 2016 Q3 | $5.45M | Sell |  | |||||
| 2016 Q2 | $6.96M | Buy |  | |||||
| 2016 Q1 | $5.33M | Buy |  | |||||
| 2015 Q4 | $6.41M | Buy |  | |||||
| 2015 Q3 | $5.48M | Buy |  | |||||
| 2015 Q2 | $5.39M | Sell |  | |||||
| 2015 Q1 | $6.04M | Sell |  | |||||
| 2014 Q4 | $5.63M | Buy |  | |||||
| 2014 Q3 | $5.08M | Buy |  | |||||
| 2014 Q2 | $4.88M | Buy |  | |||||
| 2014 Q1 | $4.86M | Sell |  | |||||
| 2013 Q4 | $5.04M | Buy |  | |||||
| 2013 Q3 | $3.81M | Buy |  | |||||
| 2013 Q2 | $3.49M | Buy |  |